StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
LYELLyell Immunopharma, Inc.
stockpulse.co.kr
Nasdaq
$9.37▲ 0.00%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $218.6MShares out 23.3M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

17
  • 10.13After-hours26.10.14 06:17
    4Ownership#●●●#●●●

    Lyell Immunopharma, Inc.

    Lyell Immunopharma insider Jarrad Mattieu Aguirre reported a change in beneficial ownership of securities as of October 12, 2026. This filing serves as a standard disclosure regarding insider stock holdings.…more

    $9.37+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 9.10After-hours26.09.11 08:37
    4Ownership

    Lyell Immunopharma, Inc.

    Insider David Shook of Lyell Immunopharma, Inc. filed a Form 4 on September 10, 2026, to report changes in beneficial ownership of securities. This filing serves as an official disclosure of insider equity transactions to the SEC.…more

    $9.37+0.00%vs prev close
    View filingShare
  • 9.10After-hours26.09.11 08:31
    4Ownership

    Lyell Immunopharma, Inc.

    Insider Jarrad Mattieu Aguirre of Lyell Immunopharma, Inc. filed a Form 4 on September 10, 2026, reporting changes in beneficial ownership of securities. This filing serves to disclose the insider's updated equity position to the market.…more

    $9.37+0.00%vs prev close
    View filingShare

16 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire
  • 9.14Pre-market26.09.14 20:00
    #●●●#●●●

    Lyell Immunopharma to Participate in Baird Global Healthcare Conference…more

    Lyell Immunopharma announced that its management team will participate in the upcoming Baird 2026 Global Healthcare Conference. This event is a standard investor relations activity and does not provide new material financial or clinical updates.…more

    $9.37+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    Read sourceShareGlobeNewswire
  • 9.10After-hours26.09.11 05:05

    ●●●●●●●● ●●●●● ●●●●●●

    Lyell Immunopharma has completed the technology transfer for its LYL273 manufacturing process following FDA review. The company now expects to share additional clinical data and hold an End-of-Phase 1 meeting with the FDA in 2027.…more

    $9.37+0.00%vs prev close
    Read sourceShareGlobeNewswire

1 more news items

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →